Genetic polymorphisms modify the response of factor VII to oral contraceptive use: an example of gene–environment interaction-Reference-Cited by-同舟云学术

Genetic polymorphisms modify the response of factor VII to oral contraceptive use: an example of gene–environment interaction

Published:2002-08 Issue:3 Volume:39 Page:131-136
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

Bloemenkamp Kitty W.M,de Maat Moniek P.M,Dersjant-Roorda Marianne C,Helmerhorst Frans M,Kluft Cornelis

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine,Physiology

Reference40 articles.

1. Evidence that currently available pills are associated with cardiovascular disease: venous disease;Bloemenkamp,1996

2. A comparative clinical investigation of two low-dose oral contraceptives containing either 75 μg gestodene or 150 μg desogestrel combined with 20 μg ethinylestradiol: effect on hemostasis, lipid metabolism and carbohydrate metabolism;Bloemenkamp;Gynecol. Endocrinol.,1998

3. Consensus Development Meeting 1995: combined oral contraceptives and cardiovascular disease;Gynecol. Endocrinol.,1996

4. Factor VII polymorphisms in populations with different risks of cardiovascular disease;de Maat;Arterioscler. Thromb. Vasc. Biol.,1997

5. Association between polymorphisms in the fibrinogen alpha- and beta-genes on the post-trauma fibrinogen increase;Ferrer Antunes;Thromb. Res.,1998

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The significance of published polymorphisms in 14 cases of mild factor VII deficiency;Blood Coagulation & Fibrinolysis;2005-03

2. Elevated factor VII as a risk factor for recurrent fetal loss;Thrombosis and Haemostasis;2005

3. Contraception in Women with Autoimmune Diseases;Handbook of Systemic Autoimmune Diseases;2005

4. Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk;Thrombosis and Haemostasis;2004